Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2018 Filed Jun 4, 2018 20:44 UTC |
ABRAMS MARKDirector
|
GrantCommon Stock | 5,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-027114 · doc1.xml · nonDerivative · entry 2 ABRAMS MARK · CIK 0001286122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,827 F2 · kind: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest on the first anniversary of the grant date and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock. F3 · price: Each RSU has the economic equivalent of one share of Chimera common stock. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 16:45 UTC |
Mahoney DennisDirector
|
GrantCommon Stock | 2,313 | $18.02 | $41,680.26 |
DisclosureSEC source: 0001140361-18-027115 · doc1.xml · nonDerivative · entry 1 Mahoney Dennis · CIK 0001488524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,866 F1 · shares: The reporting person has elected to defer the shares under the Company's Stock Deferral Plan until separation of service. F2 · price: Represents the average daily VWAP for the Company's common stock for the 20 consecutive trading days ending on the trading day immediately prior to the grant date, May 31, 2018. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 16:56 UTC |
DONLIN PAULDirector
|
GrantCommon Stock | 4,221 | $18.02 | $76,062.42 |
DisclosureSEC source: 0001140361-18-027140 · doc1.xml · nonDerivative · entry 1 DONLIN PAUL · CIK 0001418488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,975 F1 · shares: The reporting person has elected to defer the shares under the Company's Stock Deferral Plan until the earlier of January 31, 2026 or separation of service. F2 · price: Represents the average daily VWAP for the Company's common stock for the 20 consecutive trading days ending on the trading day immediately prior to the grant date, May 31, 2018. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:49 UTC |
CREAGH GERARDDirector
|
GrantCommon Stock | 2,313 | $18.02 | $41,680.26 |
DisclosureSEC source: 0001140361-18-027124 · doc1.xml · nonDerivative · entry 1 CREAGH GERARD · CIK 0001413235 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,913 F1 · shares: The reporting person has elected to defer the shares under the Company's Stock Deferral Plan until separation of service. F2 · price: Represents the average daily VWAP for the Company's common stock for the 20 consecutive trading days ending on the trading day immediately prior to the grant date, May 31, 2018. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:50 UTC |
Reilly John PatrickDirector
|
GrantCommon Stock | 4,625 | $18.02 | $83,342.50 |
DisclosureSEC source: 0001140361-18-027128 · doc1.xml · nonDerivative · entry 1 Reilly John Patrick · CIK 0001310516 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,867 F1 · shares: The reporting person has elected to defer the shares under the Company's Stock Deferral Plan until the earlier of January 31, 2021 or separation of service. F2 · price: Represents the average daily VWAP for the Company's common stock for the 20 consecutive trading days ending on the trading day immediately prior to the grant date, May 31, 2018. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:49 UTC |
STILL DEBRADirector
|
GrantCommon Stock | 1,326 | $18.02 | $23,894.52 |
DisclosureSEC source: 0001140361-18-027126 · doc1.xml · nonDerivative · entry 1 STILL DEBRA · CIK 0001733953 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,326 F1 · price: Represents the average daily VWAP for the Company's common stock for the 20 consecutive trading days ending on the trading day immediately prior to the grant date, May 31, 2018. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:46 UTC |
BAZEMORE TERESA BRYCEDirector
|
GrantCommon Stock | 2,313 | $18.02 | $41,680.26 |
DisclosureSEC source: 0001140361-18-027118 · doc1.xml · nonDerivative · entry 1 BAZEMORE TERESA BRYCE · CIK 0001721267 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,210 F1 · shares: The reporting person has elected to defer the shares under the Company's Stock Deferral Plan until separation of service. F2 · price: Represents the average daily VWAP for the Company's common stock for the 20 consecutive trading days ending on the trading day immediately prior to the grant date, May 31, 2018. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:44 UTC |
ABRAMS MARKDirector
|
GrantCommon Stock | 2,313 | $18.02 | $41,680.26 |
DisclosureSEC source: 0001140361-18-027114 · doc1.xml · nonDerivative · entry 1 ABRAMS MARK · CIK 0001286122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,293 F1 · price: Represents the average daily VWAP for the Company's common stock for the 20 consecutive trading days ending on the trading day immediately prior to the grant date, May 31, 2018. Read SEC document |
| February 20, 2018 Filed Feb 21, 2018 17:11 UTC |
LAMBIASE MATTHEWDirector · CEO, President and Director
|
GrantCommon Stock | 5,000 | $17.25 | $86,250.00 |
DisclosureSEC source: 0001140361-18-009423 · doc1.xml · nonDerivative · entry 2 LAMBIASE MATTHEW · CIK 0001419165 · Director · CEO, President and Director 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan Disclosed balance after: 32,600 F5 · balance_after: This amount reflects a reduction of 5,000 shares that were previously reported as owned due to a typographical error in Reporting Person's Form 4s since 8/24/2015. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 17:11 UTC |
LAMBIASE MATTHEWDirector · CEO, President and Director
|
GrantCommon Stock | 81,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-009423 · doc1.xml · nonDerivative · entry 1 LAMBIASE MATTHEW · CIK 0001419165 · Director · CEO, President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 383,661 F1 · kind: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on the first, second and third anniversaries of the grant date and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock. F2 · shares: The reporting person elected to defer share settlement until separation of service. F3 · price: Each RSU has the economic equivalent of one share of Chimera common stock. F4 · balance_after: Dividend equivalent rights issued on RSUs are included in the reporting person's common stock holding balance. Each dividend equivalent right is the economic equivalent of one share of Chimera common stock. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 22:18 UTC |
COLLIGAN ROBERT SChief Financial Officer
|
Tax withholdingCommon Stock | 6,296 | $17.64 | $111,061.44 |
DisclosureSEC source: 0001140361-18-009429 · doc1.xml · nonDerivative · entry 2 COLLIGAN ROBERT S · CIK 0001577428 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,495 F4 · shares: Shares reported were withheld for payment of taxes associated with the vesting of prior grants of restricted stock. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 22:18 UTC |
COLLIGAN ROBERT SChief Financial Officer
|
GrantCommon Stock | 30,439 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-009429 · doc1.xml · nonDerivative · entry 1 COLLIGAN ROBERT S · CIK 0001577428 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,791 F1 · kind: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on the first, second and third anniversaries of the grant date and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock. F2 · price: Each RSU has the economic equivalent of one share of Chimera common stock. F3 · balance_after: Dividend equivalent rights issued on RSUs are included in the reporting person's common stock holding balance. Each dividend equivalent right is the economic equivalent of one share of Chimera common stock. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 22:08 UTC |
Kardis Phillip John IIDirector · Chief Legal Officer
|
Tax withholdingCommon Stock | 20,321 | $17.64 | $358,462.44 |
DisclosureSEC source: 0001140361-18-009422 · doc1.xml · nonDerivative · entry 2 Kardis Phillip John II · CIK 0001652530 · Director · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,795 F4 · shares: Shares reported were withheld for payment of taxes associated with the vesting of prior grants of restricted stock. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 22:08 UTC |
Kardis Phillip John IIDirector · Chief Legal Officer
|
GrantCommon Stock | 42,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-009422 · doc1.xml · nonDerivative · entry 1 Kardis Phillip John II · CIK 0001652530 · Director · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,116 F1 · kind: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on the first, second and third anniversaries of the grant date and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock. F2 · price: Each RSU has the economic equivalent of one share of Chimera common stock. F3 · balance_after: Dividend equivalent rights issued on RSUs are included in the reporting person's common stock holding balance. Each dividend equivalent right is the economic equivalent of one share of Chimera common stock. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 22:02 UTC |
Yarlagadda ChoudharyChief Operating Officer
|
GrantCommon Stock | 54,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-009406 · doc1.xml · nonDerivative · entry 1 Yarlagadda Choudhary · CIK 0001650531 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,974 F1 · kind: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on the first, second and third anniversaries of the grant date and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock. F2 · shares: The reporting person elected to defer share settlement until separation of service. F3 · price: Each RSU has the economic equivalent of one share of Chimera common stock. F4 · balance_after: Dividend equivalent rights issued on RSUs are included in the reporting person's common stock holding balance. Each dividend equivalent right is the economic equivalent of one share of Chimera common stock. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 21:55 UTC |
MARRIA MOHITChief Investment Officer
|
Tax withholdingCommon Stock | 1,800 | $17.64 | $31,752.00 |
DisclosureSEC source: 0001140361-18-009399 · doc1.xml · nonDerivative · entry 2 MARRIA MOHIT · CIK 0001594020 · Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,842 F5 · shares: Shares reported were withheld for payment of taxes associated with the vesting of prior grants of restricted stock. Read SEC document |
| February 16, 2018 Filed Feb 21, 2018 21:55 UTC |
MARRIA MOHITChief Investment Officer
|
GrantCommon Stock | 32,468 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-009399 · doc1.xml · nonDerivative · entry 1 MARRIA MOHIT · CIK 0001594020 · Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,642 F1 · kind: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on the first, second and third anniversaries of the grant date and shall be settled 100% in shares of Chimera common stock. F2 · shares: The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock. F3 · price: The reporting person elected to defer share settlement until separation of service. F4 · balance_after: Each RSU has the economic equivalent of one share of Chimera common stock. Dividend equivalent rights issued on RSUs are included in the reporting person's common stock holding balance. Each dividend equivalent right is the economic equivalent of one share of Chimera common stock. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 02:20 UTC |
MARRIA MOHITChief Investment Officer
|
Purchase8.00% Series A Cumulative Redeemable Preferred Stock | 3,000 | $25.82 | $77,460.00 |
DisclosureSEC source: 0001140361-18-000285 · doc1.xml · nonDerivative · entry 3 MARRIA MOHIT · CIK 0001594020 · Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 3,000 Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 16:17 UTC |
Mahoney DennisDirector
|
GrantCommon Stock | 5,378 | $18.60 | $100,003.91 |
DisclosureSEC source: 0001140361-17-046502 · doc1.xml · nonDerivative · entry 1 Mahoney Dennis · CIK 0001488524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,747 F1 · shares: The reporting person has elected to defer the shares under the Company's Stock Deferral Plan until separation of service. F2 · price: Represents the average daily VWAP for the Company's common stock for the 20 consecutive trading days ending on the trading day immediately prior to the grant date, December 15, 2017. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 16:31 UTC |
KEENAN PAUL ADirector
|
GrantCommon Stock | 11,832 | $18.60 | $220,016.04 |
DisclosureSEC source: 0001140361-17-046524 · doc1.xml · nonDerivative · entry 1 KEENAN PAUL A · CIK 0001419224 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,843 F1 · shares: The reporting person has elected to defer the shares under the Company's Stock Deferral Plan until separation of service. F2 · price: Represents the average daily VWAP for the Company's common stock for the 20 consecutive trading days ending on the trading day immediately prior to the grant date, December 15, 2017. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 16:24 UTC |
DONLIN PAULDirector
|
GrantCommon Stock | 9,815 | $18.60 | $182,509.93 |
DisclosureSEC source: 0001140361-17-046508 · doc1.xml · nonDerivative · entry 1 DONLIN PAUL · CIK 0001418488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,619 F1 · shares: The reporting person has elected to defer the shares under the Company's Stock Deferral Plan until separation of service. F2 · price: Represents the average daily VWAP for the Company's common stock for the 20 consecutive trading days ending on the trading day immediately prior to the grant date, December 15, 2017. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 21:23 UTC |
ABRAMS MARKDirector
|
GrantCommon Stock | 5,378 | $18.60 | $100,003.91 |
DisclosureSEC source: 0001140361-17-046506 · doc1.xml · nonDerivative · entry 1 ABRAMS MARK · CIK 0001286122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,980 F1 · price: Represents the average daily VWAP for the Company's common stock for the 20 consecutive trading days ending on the trading day immediately prior to the grant date, December 15, 2017. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 21:26 UTC |
CREAGH GERARDDirector
|
GrantCommon Stock | 5,378 | $18.60 | $100,003.91 |
DisclosureSEC source: 0001140361-17-046510 · doc1.xml · nonDerivative · entry 1 CREAGH GERARD · CIK 0001413235 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,363 F1 · shares: The reporting person has elected to defer the shares under the Company's Stock Deferral Plan until separation of service. F2 · price: Represents the average daily VWAP for the Company's common stock for the 20 consecutive trading days ending on the trading day immediately prior to the grant date, December 15, 2017. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 21:21 UTC |
Reilly John PatrickDirector
|
GrantCommon Stock | 10,756 | $18.60 | $200,007.82 |
DisclosureSEC source: 0001140361-17-046504 · doc1.xml · nonDerivative · entry 1 Reilly John Patrick · CIK 0001310516 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,298 F1 · shares: The reporting person has elected to defer the shares under the Company's Stock Deferral Plan until the earlier of January 31, 2020 or separation of service. F2 · price: Represents the average daily VWAP for the Company's common stock for the 20 consecutive trading days ending on the trading day immediately prior to the grant date, December 15, 2017. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 21:15 UTC |
BAZEMORE TERESA BRYCEDirector
|
GrantCommon Stock | 897 | $18,595.00 | $16,679,715.00 |
DisclosureSEC source: 0001140361-17-046499 · doc1.xml · nonDerivative · entry 1 BAZEMORE TERESA BRYCE · CIK 0001721267 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 897 F1 · price: Represents the average daily VWAP for the Company's common stock for the 20 consecutive trading days ending on the trading day immediately prior to the grant date, December 15, 2017. Read SEC document |
| December 15, 2017 Filed Jun 4, 2018 16:53 UTC |
KEENAN PAUL ADirector
|
GrantCommon Stock | 4,972 | $18.02 | $89,595.44 |
DisclosureSEC source: 0001140361-18-027132 · doc1.xml · nonDerivative · entry 1 KEENAN PAUL A · CIK 0001419224 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,341 F1 · shares: The reporting person has elected to defer the shares under the Company's Stock Deferral Plan until separation of service. F2 · price: Represents the average daily VWAP for the Company's common stock for the 20 consecutive trading days ending on the trading day immediately prior to the grant date, May 31, 2018. Read SEC document |
| November 06, 2017 Filed Nov 8, 2017 21:57 UTC |
MARRIA MOHITChief Investment Officer
|
PurchaseCommon Stock | 6,625 | $17.89 | $118,521.25 |
DisclosureSEC source: 0001140361-17-041616 · doc1.xml · nonDerivative · entry 2 MARRIA MOHIT · CIK 0001594020 · Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan Disclosed balance after: 29,236 Read SEC document |
| May 09, 2017 Filed May 11, 2017 20:20 UTC |
CREAGH GERARDDirector
|
GrantCommon Stock | 10,000 | $17.82 | $178,200.00 |
DisclosureSEC source: 0001140361-17-019762 · doc1.xml · nonDerivative · entry 1 CREAGH GERARD · CIK 0001413235 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,897 Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 17:48 UTC |
LAMBIASE MATTHEWDirector · CEO, President and Director
|
Tax withholdingCommon Stock | 4,055 | $18.71 | $75,869.05 |
DisclosureSEC source: 0001140361-17-008417 · doc1.xml · nonDerivative · entry 2 LAMBIASE MATTHEW · CIK 0001419165 · Director · CEO, President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,250 F5 · shares: Shares reported were withheld for payment of taxes associated with the vesting of approximately one-third of a grant of restricted stock originally made in February 2016. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 17:48 UTC |
LAMBIASE MATTHEWDirector · CEO, President and Director
|
GrantCommon Stock | 29,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008417 · doc1.xml · nonDerivative · entry 1 LAMBIASE MATTHEW · CIK 0001419165 · Director · CEO, President and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,305 F1 · kind: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on the first, second and third anniversaries of the grant date and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock. F2 · shares: The reporting person elected to defer share settlement until separation of service. F3 · price: Each RSU has the economic equivalent of one share of Chimera common stock. F4 · balance_after: Dividend equivalent rights issued on RSUs are included in the reporting person's common stock holding balance. Each dividend equivalent right is the economic equivalent of one share of Chimera common stock. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 23:00 UTC |
MARRIA MOHITChief Investment Officer
|
Tax withholdingCommon Stock | 6,260 | $18.71 | $117,124.60 |
DisclosureSEC source: 0001140361-17-008423 · doc1.xml · nonDerivative · entry 2 MARRIA MOHIT · CIK 0001594020 · Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,950 F5 · shares: Shares reported were withheld for payment of taxes associated with the vesting of approximately one-third of a grant of restricted stock originally made in February 2015 and February 2016. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 23:00 UTC |
MARRIA MOHITChief Investment Officer
|
GrantCommon Stock | 11,751 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008423 · doc1.xml · nonDerivative · entry 1 MARRIA MOHIT · CIK 0001594020 · Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,210 F1 · kind: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on the first, second and third anniversaries of the grant date and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock. F2 · shares: The reporting person elected to defer share settlement until separation of service. F3 · price: Each RSU has the economic equivalent of one share of Chimera common stock. F4 · balance_after: Dividend equivalent rights issued on RSUs are included in the reporting person's common stock holding balance. Each dividend equivalent right is the economic equivalent of one share of Chimera common stock Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 22:49 UTC |
COLLIGAN ROBERT SChief Financial Officer
|
Tax withholdingCommon Stock | 6,839 | $18.71 | $127,957.69 |
DisclosureSEC source: 0001140361-17-008420 · doc1.xml · nonDerivative · entry 2 COLLIGAN ROBERT S · CIK 0001577428 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,953 F5 · shares: Shares reported were withheld for payment of taxes associated with the vesting of approximately one-third of a grant of restricted stock originally made in February 2015 and February 2016. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 22:49 UTC |
COLLIGAN ROBERT SChief Financial Officer
|
GrantCommon Stock | 11,017 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008420 · doc1.xml · nonDerivative · entry 1 COLLIGAN ROBERT S · CIK 0001577428 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,792 F1 · kind: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on the first, second and third anniversaries of the grant date and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock. F2 · shares: The reporting person elected to defer 50% of the share settlement of this award until the earlier of separation of service or January 31, 2022. F3 · price: Each RSU has the economic equivalent of one share of Chimera common stock. F4 · balance_after: Dividend equivalent rights issued on RSUs are included in the reporting person's common stock holding balance. Each dividend equivalent right is the economic equivalent of one share of Chimera common stock. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 22:34 UTC |
Yarlagadda ChoudharyChief Operating Officer
|
Tax withholdingCommon Stock | 2,367 | $18.71 | $44,286.57 |
DisclosureSEC source: 0001140361-17-008404 · doc1.xml · nonDerivative · entry 2 Yarlagadda Choudhary · CIK 0001650531 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,561 F5 · shares: Shares reported were withheld for payment of taxes associated with the vesting of approximately one-third of a grant of restricted stock originally made in February 2016. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 22:34 UTC |
Yarlagadda ChoudharyChief Operating Officer
|
GrantCommon Stock | 19,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008404 · doc1.xml · nonDerivative · entry 1 Yarlagadda Choudhary · CIK 0001650531 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,928 F1 · kind: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on the first, second and third anniversaries of the grant date and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock. F2 · shares: The reporting person elected to defer share settlement until separation of service. F3 · price: Each RSU has the economic equivalent of one share of Chimera common stock. F4 · balance_after: Dividend equivalent rights issued on RSUs are included in the reporting person's common stock holding balance. Each dividend equivalent right is the economic equivalent of one share of Chimera common stock. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 22:41 UTC |
Kardis Phillip John IIChief Legal Officer
|
Tax withholdingCommon Stock | 12,210 | $18.71 | $228,449.10 |
DisclosureSEC source: 0001140361-17-008414 · doc1.xml · nonDerivative · entry 2 Kardis Phillip John II · CIK 0001652530 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,764 F4 · shares: Shares reported were withheld for payment of taxes associated with the vesting of approximately one-third of a grant of restricted stock originally made in February 2016. Read SEC document |
| February 16, 2017 Filed Feb 21, 2017 22:41 UTC |
Kardis Phillip John IIChief Legal Officer
|
GrantCommon Stock | 40,086 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-008414 · doc1.xml · nonDerivative · entry 1 Kardis Phillip John II · CIK 0001652530 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,974 F1 · kind: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on the first, second and third anniversaries of the grant date and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock. F2 · price: Each RSU has the economic equivalent of one share of Chimera common stock. F3 · balance_after: Dividend equivalent rights issued on RSUs are included in the reporting person's common stock holding balance. Each dividend equivalent right is the economic equivalent of one share of Chimera common stock. Read SEC document |
| February 16, 2017 Filed Feb 28, 2017 22:22 UTC Amendment |
MARRIA MOHITChief Investment Officer
|
Tax withholdingCommon Stock | 3,988 | $18.71 | $74,615.48 |
DisclosureSEC source: 0001140361-17-009740 · doc1.xml · nonDerivative · entry 2 MARRIA MOHIT · CIK 0001594020 · Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,222 F5 · shares: Shares reported were withheld for payment of taxes associated with the vesting of approximately one-third of a grant of restricted stock originally made in February 2015 and February 2016. Read SEC document |
| February 16, 2017 Filed Feb 28, 2017 22:22 UTC Amendment |
MARRIA MOHITChief Investment Officer
|
GrantCommon Stock | 11,751 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-009740 · doc1.xml · nonDerivative · entry 1 MARRIA MOHIT · CIK 0001594020 · Chief Investment Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,210 F1 · kind: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on the first, second and third anniversaries of the grant date and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock. F2 · shares: The reporting person elected to defer share settlement until separation of service. F3 · price: Each RSU has the economic equivalent of one share of Chimera common stock. F4 · balance_after: Dividend equivalent rights issued on RSUs are included in the reporting person's common stock holding balance. Each dividend equivalent right is the economic equivalent of one share of Chimera common stock Read SEC document |
| February 16, 2017 Filed Feb 28, 2017 22:16 UTC Amendment |
COLLIGAN ROBERT SChief Financial Officer
|
Tax withholdingCommon Stock | 9,111 | $18.17 | $165,546.87 |
DisclosureSEC source: 0001140361-17-009739 · doc1.xml · nonDerivative · entry 2 COLLIGAN ROBERT S · CIK 0001577428 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,681 F5 · shares: Shares reported were withheld for payment of taxes associated with the vesting of approximately one-third of a grant of restricted stock originally made in February 2015 and February 2016. Read SEC document |
| February 16, 2017 Filed Feb 28, 2017 22:16 UTC Amendment |
COLLIGAN ROBERT SChief Financial Officer
|
GrantCommon Stock | 11,017 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-009739 · doc1.xml · nonDerivative · entry 1 COLLIGAN ROBERT S · CIK 0001577428 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,792 F1 · kind: Represents shares of Chimera common stock underlying restricted stock units ("RSUs"). The RSUs are scheduled to vest one-third per year on the first, second and third anniversaries of the grant date and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock. F2 · shares: The reporting person elected to defer 50% of the share settlement of this award until the earlier of separation of service on January 31, 2022. F3 · price: Each RSU has the economicequivalent of one share of Chimera common stock. F4 · balance_after: Dividend equivalent rights issued on RSUs are included in the reporting person's common stock holding balance. Each dividend equivalent right is the economic equivalent of one share of Chimera common stock. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 16:53 UTC |
Mahoney DennisDirector
|
GrantCommon Stock | 5,877 | $17.02 | $100,026.54 |
DisclosureSEC source: 0001140361-16-090265 · doc1.xml · nonDerivative · entry 1 Mahoney Dennis · CIK 0001488524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,520 F1 · shares: The reporting person has elected to defer 4,897 shares under the Company's Stock Deferral Plan until separation of service. F2 · price: Represents the average daily VWAP for the Company's common stock for the 20 consecutive trading days ending on the trading day immediately prior to the grant date, December 15, 2016. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 16:31 UTC |
KEENAN PAUL ADirector
|
GrantCommon Stock | 12,926 | $17.02 | $220,000.52 |
DisclosureSEC source: 0001140361-16-090252 · doc1.xml · nonDerivative · entry 1 KEENAN PAUL A · CIK 0001419224 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,577 F1 · shares: The reporting person has elected to defer the shares under the Company's Stock Deferral Plan until separation of service. F2 · price: Represents the average daily VWAP for the Company's common stock for the 20 consecutive trading days ending on the trading day immediately prior to the grant date, December 15, 2016. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 16:48 UTC |
DONLIN PAULDirector
|
GrantCommon Stock | 9,671 | $17.02 | $164,600.42 |
DisclosureSEC source: 0001140361-16-090264 · doc1.xml · nonDerivative · entry 1 DONLIN PAUL · CIK 0001418488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,840 F1 · shares: The reporting person has elected to defer 8,691 shares under the Company's Stock Deferral Plan until January 31, 2019. F2 · price: Represents the average daily VWAP for the Company's common stock for the 20 consecutive trading days ending on the trading day immediately prior to the grant date, December 15, 2016. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 21:31 UTC |
CREAGH GERARDDirector
|
GrantCommon Stock | 5,877 | $17.02 | $100,026.54 |
DisclosureSEC source: 0001140361-16-090253 · doc1.xml · nonDerivative · entry 1 CREAGH GERARD · CIK 0001413235 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,897 F1 · shares: The reporting person has elected to defer 4,897 shares under the Company's Stock Deferral Plan until separation of service. F2 · price: Represents the average daily VWAP for the Company's common stock for the 20 consecutive trading days ending on the trading day immediately prior to the grant date, December 15, 2016. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 21:41 UTC |
Reilly John PatrickDirector
|
GrantCommon Stock | 5,877 | $17.02 | $100,026.54 |
DisclosureSEC source: 0001140361-16-090259 · doc1.xml · nonDerivative · entry 1 Reilly John Patrick · CIK 0001310516 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,997 F1 · shares: The reporting person has elected to defer 4,897 shares under the Company's Stock Deferral Plan until separation of service. F2 · price: Represents the average daily VWAP for the Company's common stock for the 20 consecutive trading days ending on the trading day immediately prior to the grant date, December 15, 2016. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 21:34 UTC |
ABRAMS MARKDirector
|
GrantCommon Stock | 5,876 | $17.02 | $100,009.52 |
DisclosureSEC source: 0001140361-16-090256 · doc1.xml · nonDerivative · entry 1 ABRAMS MARK · CIK 0001286122 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,602 F1 · price: Represents the average daily VWAP for the Company's common stock for the 20 consecutive trading days ending on the trading day immediately prior to the grant date, December 15, 2016. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 20:20 UTC |
Yarlagadda ChoudharyChief Operating Officer
|
PurchaseCommon Stock | 640 | $16.13 | $10,323.20 |
DisclosureSEC source: 0001140361-16-079677 · doc1.xml · nonDerivative · entry 3 Yarlagadda Choudhary · CIK 0001650531 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 243,445 F1 · ownership.nature: The reporting person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 20:20 UTC |
Yarlagadda ChoudharyChief Operating Officer
|
PurchaseCommon Stock | 265 | $16.08 | $4,261.20 |
DisclosureSEC source: 0001140361-16-079677 · doc1.xml · nonDerivative · entry 2 Yarlagadda Choudhary · CIK 0001650531 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 242,805 F1 · ownership.nature: The reporting person disclaims beneficial ownership of these shares and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.